title: Pharmaceutical approval update.
abstract: Filgrastim-sndz (Zarxio) to help prevent infections related to chemotherapy, dinutuximab (Unituxin) for high-risk pediatric neuroblastoma, and panobinostat (Farydak) for multiple myeloma.
authors.forename: Kunj
authors.initials: K
authors.lastname: Gohil